Definitive Contract HHSN261201300053C
Award Date
9/13/13
Potential Completion Date
6/12/14
Potential Value
$200K
Federal Agency
National Cancer Institute
Awardee
Base Pair Biotechnologies Inc.
Ultimate Awardee
Not listed
NAICS Category
541711 - Research and Development in Biotechnology
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Houston, TX 77054, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
15
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC), an agency within the Department of Health and Human Services (HHS), to Base Pair Biotechnologies Inc. for $149,000.00. The contract is for the delivery of DNA affinity probes, which are likely to be used in biomedical research and healthcare applications. Base Pair Biotechnologies is a for-profit company that specializes in custom aptamer development services, including aptamer discovery...
This is a $125,000.04 firm-fixed price purchase order awarded by the Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) to Base Pair Biotechnologies Inc., a for-profit company that provides custom aptamer development services and products. The contract is for aptamer development services, and does not have a set-aside designation. Through prior contracts and grants, Base Pair Biotechnologies has provided research and development services related to...
This is a $300,000.00 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institutes of Health (NIH) National Cancer Institute to Base Pair Biotechnologies Inc., a for-profit company that provides custom aptamer development services and products to the federal government. The contract is for the "Development and Validation of Non-Mouse Reagents to Enable Preclinical Development of Novel Therapeutics", which was one of the research topics identified in the...
This is a $300,000.00 Firm Fixed Price Definitive Contract awarded by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services, to Base Pair Biotechnologies Inc., a small business concern, to develop aptasensors for measuring long-term adherence to tenofovir-based and long-acting HIV treatment regimens. The contract was awarded under the Small Business Innovation Research (SBIR) program, which is designed to stimulate technological...
This is a firm fixed price BPA call contract awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, to Life Technologies Corporation, a for-profit manufacturer of scientific instruments, reagents, and consumables. The $10,158.75 contract has an ultimate completion date of July 29, 2024 and does not utilize a set-aside. Life Technologies serves as a prime contractor to the NCI, providing specialized biotechnology products and services...
This is a $199,828 Firm Fixed Price contract awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services, to A&G Pharmaceutical, Inc. (doing business as Precision Antibody) for the development of "TECHNOLOGY GENERATED ANTI-PEPTIDE CAPTURE REAGENTS FOR AFFINITY ENRICHED PROTEOMIC STUDIES." The contract has a performance period ending on July 24, 2014 and was awarded on September 25, 2013. Precision Antibody is a for-profit...
This $22,043.55 firm-fixed-price contract was awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Life Technologies Corporation. The contract is a Blanket Purchase Agreement (BPA) call that provides the NCI with various scientific instruments, reagents, and consumables to support biomedical research, applied markets, and forensic analysis. Life Technologies, a manufacturer of scientific equipment and a subsidiary of Thermo...
This $3,652.47 firm fixed price BPA call contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific. The contract is for the provision of lab supplies, with a period of performance ending on April 30, 2015. No set-aside designation was used. Life Technologies has served as a prime contractor across various federal agencies,...
This is a federal service agreement awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. government, to Life Technologies Corporation, doing business as Thermo Fisher Scientific. The $17,308.20 firm fixed-price contract is a blanket purchase agreement (BPA) call order with a completion date of May 3, 2026. The award does not have a set-aside designation, indicating Life Technologies competed openly for the contract. As a prominent manufacturer of scientific...
This federal contract award was made by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The $3,932 firm-fixed-price BPA call contract is for the delivery of genetic analysis products and associated services to support NCI's biomedical research initiatives. As a division of Thermo Fisher Scientific, Life Technologies serves as a...